Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
Clinical trial NCT03066557 · UNKNOWN
Trial details
- NCT number
- NCT03066557
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-15
- Primary completion
- 2018-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.